Hedge fund Voce's nominees elected to Natus board
(Reuters) - Natus Clinical Inc mentioned on Friday its stockholders had elected hedge fund Voce Capital Control’s nominees to the corporate’s board, finishing a months lengthy proxy struggle.
The clinical instrument maker additionally mentioned the initial depend of votes confirmed that its stockholders had voted to reject Voce’s proposal to take away the corporate’s Chairman, Robert Gunst.
Voce’s nominees, Lisa Wipperman Heine and Joshua Levine will change Doris Engibous and Robert Weiss on Natus’s board.
The hedge fund mentioned, in accordance with a initial record, its nominees gained just about 70 p.c of the stocks voted within the election.
Voce, run by means of Daniel Crops, owns 2.2 p.c of Natus and tensions were emerging since March, when Crops requested for a gathering with the corporate’s board chairman and unbiased administrators.
Natus stocks rose three p.c in past due afternoon buying and selling.
Reporting by means of Uday Sampath in Bengaluru; Enhancing by means of Shailesh Kuber
Our Requirements:The Thomson Reuters Agree with Ideas.Original ArticleEconomy
0 comments:
Post a Comment